Dehradun’s Top Diagnostic Chain Sold for Rs 35 Crore in Major North India Expansion Move

DSIJ Intelligence
/ Categories: Trending, Mindshare
Dehradun’s Top Diagnostic Chain Sold for Rs 35 Crore in Major North India Expansion Move

Deal Marks Strategic Step to Strengthen Presence Across Tier-2 Cities in the Region

Metropolis Healthcare Limited, one of India’s top diagnostic chains, has announced the acquisition of Dr. Ahujas’ Pathology & Imaging Centre (DAPIC), Dehradun’s leading diagnostic player. The deal was signed through its wholly owned subsidiary, Metropolis Histoxpert Digital Services. The all-cash deal is valued at Rs 35.01 crore, and Metropolis will gain 100 per cent ownership of DAPIC.

About Dr. Ahujas’ Pathology & Imaging Centre
 DAPIC was founded in 1990 by Dr. Alok Ahuja and Dr. Alka Ahuja. It operates two NABL and NABH accredited labs, 11 patient service centres, and nine hospital-based centres in Uttarakhand. It offers pathology and radiology services such as ultrasound, ECG, and X-ray. In FY25, DAPIC posted estimated revenue of Rs 11.5 crore, with 73 per cent coming from pathology and 27 per cent from radiology. About 80 per cent of its business comes from walk-in patients, giving it strong B2C reach.

Strategic Fit for Metropolis
This acquisition is part of Metropolis’ 'String of Pearls' strategy to expand its regional presence. Previous acquisitions in North India include Core Diagnostics and Scientific Pathology. With the addition of DAPIC, the North India contribution to overall revenue has grown from 8 per cent to nearly 15 per cent. Metropolis plans to expand further across Uttar Pradesh and Uttarakhand.

Future Plans and Integration
Dr. Ahuja and Dr. Alka Ahuja will continue with the business during the transition. Metropolis now becomes the second-largest diagnostic chain in Uttarakhand. The company plans to expand accessibility using a franchise model and strengthen both B2C and B2B offerings with a wider test portfolio.

Advisors Involved
EY acted as the exclusive financial advisor to DAPIC, while BDO India LLP advised Metropolis Healthcare in the transaction.

Disclaimer: The article is for informational purposes only and not investment advice.

Rate this article:
5.0

Leave a comment

Add comment

DSIJ MINDSHARE

Mkt Commentary7-Apr, 2025

Mindshare7-Apr, 2025

Mindshare7-Apr, 2025

Multibaggers7-Apr, 2025

Mindshare7-Apr, 2025

Knowledge

General22-Mar, 2025

MF14-Mar, 2025

MF14-Mar, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR